nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—ABCB1—colon cancer	0.227	1	CbGaD
Dipyridamole—SLC29A1—Fluorouracil—colon cancer	0.196	0.398	CbGbCtD
Dipyridamole—ABCC5—Fluorouracil—colon cancer	0.15	0.304	CbGbCtD
Dipyridamole—ABCC4—Fluorouracil—colon cancer	0.0721	0.146	CbGbCtD
Dipyridamole—ABCC4—Methotrexate—colon cancer	0.0397	0.0806	CbGbCtD
Dipyridamole—ABCB1—Irinotecan—colon cancer	0.0146	0.0295	CbGbCtD
Dipyridamole—ABCB1—Vincristine—colon cancer	0.0127	0.0258	CbGbCtD
Dipyridamole—ABCB1—Methotrexate—colon cancer	0.00771	0.0156	CbGbCtD
Dipyridamole—PDE11A—epithelium—colon cancer	0.003	0.0355	CbGeAlD
Dipyridamole—PRUNE—Vinorelbine—Vincristine—colon cancer	0.00273	0.593	CbGdCrCtD
Dipyridamole—PDE5A—endothelium—colon cancer	0.00254	0.0301	CbGeAlD
Dipyridamole—PDE6B—lymphoid tissue—colon cancer	0.00249	0.0294	CbGeAlD
Dipyridamole—PDE7A—renal system—colon cancer	0.00248	0.0293	CbGeAlD
Dipyridamole—PDE5A—blood vessel—colon cancer	0.00235	0.0277	CbGeAlD
Dipyridamole—PDE6D—bone marrow—colon cancer	0.0023	0.0272	CbGeAlD
Dipyridamole—PDE6D—vagina—colon cancer	0.0022	0.0261	CbGeAlD
Dipyridamole—PDE6B—vagina—colon cancer	0.00217	0.0257	CbGeAlD
Dipyridamole—PDE7A—lymphoid tissue—colon cancer	0.00206	0.0244	CbGeAlD
Dipyridamole—PRUNE—liver—colon cancer	0.00193	0.0228	CbGeAlD
Dipyridamole—PRUNE—Vinblastine—Vincristine—colon cancer	0.00188	0.407	CbGdCrCtD
Dipyridamole—PDE6D—liver—colon cancer	0.00186	0.022	CbGeAlD
Dipyridamole—PDE11A—liver—colon cancer	0.0017	0.0201	CbGeAlD
Dipyridamole—PDE6G—liver—colon cancer	0.00164	0.0194	CbGeAlD
Dipyridamole—PDE1C—lymph node—colon cancer	0.00164	0.0194	CbGeAlD
Dipyridamole—PDE8A—smooth muscle tissue—colon cancer	0.00161	0.0191	CbGeAlD
Dipyridamole—PDE1A—smooth muscle tissue—colon cancer	0.00156	0.0185	CbGeAlD
Dipyridamole—PDE1A—renal system—colon cancer	0.0015	0.0178	CbGeAlD
Dipyridamole—PDE10A—digestive system—colon cancer	0.00148	0.0176	CbGeAlD
Dipyridamole—PRUNE—lymph node—colon cancer	0.00148	0.0175	CbGeAlD
Dipyridamole—PDE6D—lymph node—colon cancer	0.00143	0.0169	CbGeAlD
Dipyridamole—PDE7B—liver—colon cancer	0.00132	0.0157	CbGeAlD
Dipyridamole—PDE2A—vagina—colon cancer	0.00131	0.0155	CbGeAlD
Dipyridamole—ADA—renal system—colon cancer	0.00128	0.0151	CbGeAlD
Dipyridamole—PDE3B—bone marrow—colon cancer	0.00127	0.0151	CbGeAlD
Dipyridamole—PDE6G—lymph node—colon cancer	0.00126	0.0148	CbGeAlD
Dipyridamole—PDE8B—vagina—colon cancer	0.00125	0.0148	CbGeAlD
Dipyridamole—PDE5A—epithelium—colon cancer	0.00114	0.0135	CbGeAlD
Dipyridamole—PDE8A—vagina—colon cancer	0.00112	0.0133	CbGeAlD
Dipyridamole—PDE2A—liver—colon cancer	0.00111	0.0131	CbGeAlD
Dipyridamole—PDE5A—smooth muscle tissue—colon cancer	0.0011	0.013	CbGeAlD
Dipyridamole—PDE3A—smooth muscle tissue—colon cancer	0.00107	0.0127	CbGeAlD
Dipyridamole—ADA—lymphoid tissue—colon cancer	0.00106	0.0126	CbGeAlD
Dipyridamole—PDE5A—renal system—colon cancer	0.00106	0.0125	CbGeAlD
Dipyridamole—PDE8B—liver—colon cancer	0.00105	0.0125	CbGeAlD
Dipyridamole—ADA—digestive system—colon cancer	0.00105	0.0124	CbGeAlD
Dipyridamole—PDE3B—liver—colon cancer	0.00103	0.0122	CbGeAlD
Dipyridamole—PDE7B—lymph node—colon cancer	0.00102	0.012	CbGeAlD
Dipyridamole—ADA—bone marrow—colon cancer	0.000966	0.0114	CbGeAlD
Dipyridamole—PDE8A—liver—colon cancer	0.000949	0.0112	CbGeAlD
Dipyridamole—ADA—vagina—colon cancer	0.000926	0.011	CbGeAlD
Dipyridamole—PDE1A—liver—colon cancer	0.000918	0.0109	CbGeAlD
Dipyridamole—SLC29A1—renal system—colon cancer	0.000889	0.0105	CbGeAlD
Dipyridamole—PDE5A—digestive system—colon cancer	0.000868	0.0103	CbGeAlD
Dipyridamole—PDE2A—lymph node—colon cancer	0.000848	0.01	CbGeAlD
Dipyridamole—PDE10A—lymph node—colon cancer	0.000848	0.01	CbGeAlD
Dipyridamole—PDE1B—lymph node—colon cancer	0.00084	0.00994	CbGeAlD
Dipyridamole—PDE8B—lymph node—colon cancer	0.000809	0.00957	CbGeAlD
Dipyridamole—PDE3B—lymph node—colon cancer	0.00079	0.00935	CbGeAlD
Dipyridamole—PDE5A—vagina—colon cancer	0.000767	0.00907	CbGeAlD
Dipyridamole—SLC29A1—lymphoid tissue—colon cancer	0.000738	0.00873	CbGeAlD
Dipyridamole—ABCC5—bone marrow—colon cancer	0.000732	0.00866	CbGeAlD
Dipyridamole—SLC29A1—digestive system—colon cancer	0.000729	0.00863	CbGeAlD
Dipyridamole—PDE8A—lymph node—colon cancer	0.000728	0.00861	CbGeAlD
Dipyridamole—PDE1A—lymph node—colon cancer	0.000704	0.00833	CbGeAlD
Dipyridamole—ABCC5—vagina—colon cancer	0.000701	0.0083	CbGeAlD
Dipyridamole—SLC29A1—bone marrow—colon cancer	0.000672	0.00795	CbGeAlD
Dipyridamole—ABCC4—renal system—colon cancer	0.000671	0.00794	CbGeAlD
Dipyridamole—SLC29A1—vagina—colon cancer	0.000644	0.00762	CbGeAlD
Dipyridamole—PDE3A—liver—colon cancer	0.000629	0.00745	CbGeAlD
Dipyridamole—ADA—lymph node—colon cancer	0.000599	0.00708	CbGeAlD
Dipyridamole—ABCC5—liver—colon cancer	0.000592	0.007	CbGeAlD
Dipyridamole—PDE4A—lymph node—colon cancer	0.000583	0.0069	CbGeAlD
Dipyridamole—ABCC4—digestive system—colon cancer	0.000551	0.00651	CbGeAlD
Dipyridamole—SLC29A1—liver—colon cancer	0.000543	0.00643	CbGeAlD
Dipyridamole—ABCB1—blood vessel—colon cancer	0.000518	0.00612	CbGeAlD
Dipyridamole—ABCC4—bone marrow—colon cancer	0.000508	0.006	CbGeAlD
Dipyridamole—PDE5A—lymph node—colon cancer	0.000496	0.00587	CbGeAlD
Dipyridamole—PDE3A—lymph node—colon cancer	0.000483	0.00571	CbGeAlD
Dipyridamole—ABCC5—lymph node—colon cancer	0.000454	0.00537	CbGeAlD
Dipyridamole—SLC29A1—lymph node—colon cancer	0.000417	0.00493	CbGeAlD
Dipyridamole—ABCC4—liver—colon cancer	0.00041	0.00485	CbGeAlD
Dipyridamole—Arthritis—Capecitabine—colon cancer	0.000392	0.00407	CcSEcCtD
Dipyridamole—Cerebrovascular accident—Capecitabine—colon cancer	0.000389	0.00404	CcSEcCtD
Dipyridamole—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.000381	0.00396	CcSEcCtD
Dipyridamole—Haemoglobin—Fluorouracil—colon cancer	0.000379	0.00394	CcSEcCtD
Dipyridamole—Rhinitis—Fluorouracil—colon cancer	0.000378	0.00393	CcSEcCtD
Dipyridamole—Haemorrhage—Fluorouracil—colon cancer	0.000378	0.00392	CcSEcCtD
Dipyridamole—Cardiac disorder—Vincristine—colon cancer	0.000376	0.0039	CcSEcCtD
Dipyridamole—Hypoaesthesia—Fluorouracil—colon cancer	0.000376	0.0039	CcSEcCtD
Dipyridamole—Migraine—Capecitabine—colon cancer	0.000375	0.0039	CcSEcCtD
Dipyridamole—Pharyngitis—Fluorouracil—colon cancer	0.000375	0.00389	CcSEcCtD
Dipyridamole—Angiopathy—Vincristine—colon cancer	0.000367	0.00381	CcSEcCtD
Dipyridamole—Cardiac disorder—Irinotecan—colon cancer	0.000366	0.0038	CcSEcCtD
Dipyridamole—Flushing—Irinotecan—colon cancer	0.000366	0.0038	CcSEcCtD
Dipyridamole—Mediastinal disorder—Vincristine—colon cancer	0.000365	0.00379	CcSEcCtD
Dipyridamole—Cardiac arrest—Capecitabine—colon cancer	0.000363	0.00376	CcSEcCtD
Dipyridamole—Alopecia—Vincristine—colon cancer	0.000358	0.00371	CcSEcCtD
Dipyridamole—Angiopathy—Irinotecan—colon cancer	0.000358	0.00371	CcSEcCtD
Dipyridamole—Immune system disorder—Irinotecan—colon cancer	0.000356	0.0037	CcSEcCtD
Dipyridamole—Mediastinal disorder—Irinotecan—colon cancer	0.000355	0.00369	CcSEcCtD
Dipyridamole—Chills—Irinotecan—colon cancer	0.000354	0.00367	CcSEcCtD
Dipyridamole—Arrhythmia—Irinotecan—colon cancer	0.000352	0.00366	CcSEcCtD
Dipyridamole—Alopecia—Irinotecan—colon cancer	0.000348	0.00362	CcSEcCtD
Dipyridamole—Abdominal pain upper—Capecitabine—colon cancer	0.000348	0.00362	CcSEcCtD
Dipyridamole—Orthostatic hypotension—Capecitabine—colon cancer	0.000348	0.00362	CcSEcCtD
Dipyridamole—Pulmonary oedema—Methotrexate—colon cancer	0.000348	0.00361	CcSEcCtD
Dipyridamole—Back pain—Vincristine—colon cancer	0.000341	0.00354	CcSEcCtD
Dipyridamole—Flatulence—Irinotecan—colon cancer	0.000338	0.00351	CcSEcCtD
Dipyridamole—Arrhythmia—Fluorouracil—colon cancer	0.000337	0.0035	CcSEcCtD
Dipyridamole—Alopecia—Fluorouracil—colon cancer	0.000334	0.00346	CcSEcCtD
Dipyridamole—Back pain—Irinotecan—colon cancer	0.000332	0.00345	CcSEcCtD
Dipyridamole—Muscle spasms—Irinotecan—colon cancer	0.00033	0.00342	CcSEcCtD
Dipyridamole—Dysphagia—Capecitabine—colon cancer	0.00033	0.00342	CcSEcCtD
Dipyridamole—Anaemia—Vincristine—colon cancer	0.000326	0.00338	CcSEcCtD
Dipyridamole—Bronchospasm—Capecitabine—colon cancer	0.000324	0.00337	CcSEcCtD
Dipyridamole—Angina pectoris—Capecitabine—colon cancer	0.000321	0.00333	CcSEcCtD
Dipyridamole—Sweating increased—Capecitabine—colon cancer	0.000321	0.00333	CcSEcCtD
Dipyridamole—Ill-defined disorder—Irinotecan—colon cancer	0.000318	0.0033	CcSEcCtD
Dipyridamole—Anaemia—Irinotecan—colon cancer	0.000317	0.00329	CcSEcCtD
Dipyridamole—Vertigo—Vincristine—colon cancer	0.000317	0.00329	CcSEcCtD
Dipyridamole—Abdominal discomfort—Capecitabine—colon cancer	0.000316	0.00328	CcSEcCtD
Dipyridamole—ABCC4—lymph node—colon cancer	0.000314	0.00372	CbGeAlD
Dipyridamole—Malaise—Irinotecan—colon cancer	0.000309	0.00321	CcSEcCtD
Dipyridamole—ABCB1—embryo—colon cancer	0.000309	0.00365	CbGeAlD
Dipyridamole—Vertigo—Irinotecan—colon cancer	0.000308	0.0032	CcSEcCtD
Dipyridamole—Syncope—Irinotecan—colon cancer	0.000308	0.00319	CcSEcCtD
Dipyridamole—Convulsion—Vincristine—colon cancer	0.000305	0.00317	CcSEcCtD
Dipyridamole—Hypertension—Vincristine—colon cancer	0.000304	0.00316	CcSEcCtD
Dipyridamole—Anaemia—Fluorouracil—colon cancer	0.000304	0.00315	CcSEcCtD
Dipyridamole—Loss of consciousness—Irinotecan—colon cancer	0.000302	0.00313	CcSEcCtD
Dipyridamole—Myalgia—Vincristine—colon cancer	0.0003	0.00311	CcSEcCtD
Dipyridamole—Cough—Irinotecan—colon cancer	0.000299	0.00311	CcSEcCtD
Dipyridamole—Hypertension—Irinotecan—colon cancer	0.000296	0.00308	CcSEcCtD
Dipyridamole—Anaphylactoid reaction—Methotrexate—colon cancer	0.000293	0.00304	CcSEcCtD
Dipyridamole—Acute coronary syndrome—Capecitabine—colon cancer	0.00029	0.00301	CcSEcCtD
Dipyridamole—Cerebrovascular accident—Methotrexate—colon cancer	0.00029	0.00301	CcSEcCtD
Dipyridamole—Discomfort—Irinotecan—colon cancer	0.000289	0.003	CcSEcCtD
Dipyridamole—Myocardial infarction—Capecitabine—colon cancer	0.000288	0.00299	CcSEcCtD
Dipyridamole—Oedema—Vincristine—colon cancer	0.000288	0.00299	CcSEcCtD
Dipyridamole—Anaphylactic shock—Vincristine—colon cancer	0.000288	0.00299	CcSEcCtD
Dipyridamole—Convulsion—Fluorouracil—colon cancer	0.000285	0.00296	CcSEcCtD
Dipyridamole—Nervous system disorder—Vincristine—colon cancer	0.000282	0.00293	CcSEcCtD
Dipyridamole—Thrombocytopenia—Vincristine—colon cancer	0.000282	0.00292	CcSEcCtD
Dipyridamole—Anaphylactic shock—Irinotecan—colon cancer	0.00028	0.00291	CcSEcCtD
Dipyridamole—Oedema—Irinotecan—colon cancer	0.00028	0.00291	CcSEcCtD
Dipyridamole—Myalgia—Fluorouracil—colon cancer	0.00028	0.0029	CcSEcCtD
Dipyridamole—Chest pain—Fluorouracil—colon cancer	0.00028	0.0029	CcSEcCtD
Dipyridamole—Hyperhidrosis—Vincristine—colon cancer	0.000278	0.00289	CcSEcCtD
Dipyridamole—Discomfort—Fluorouracil—colon cancer	0.000276	0.00287	CcSEcCtD
Dipyridamole—Shock—Irinotecan—colon cancer	0.000276	0.00286	CcSEcCtD
Dipyridamole—Nervous system disorder—Irinotecan—colon cancer	0.000275	0.00285	CcSEcCtD
Dipyridamole—Thrombocytopenia—Irinotecan—colon cancer	0.000274	0.00285	CcSEcCtD
Dipyridamole—Hyperhidrosis—Irinotecan—colon cancer	0.000271	0.00281	CcSEcCtD
Dipyridamole—Hypotension—Vincristine—colon cancer	0.000269	0.00279	CcSEcCtD
Dipyridamole—Bradycardia—Capecitabine—colon cancer	0.000269	0.00279	CcSEcCtD
Dipyridamole—Oedema—Fluorouracil—colon cancer	0.000268	0.00278	CcSEcCtD
Dipyridamole—Anaphylactic shock—Fluorouracil—colon cancer	0.000268	0.00278	CcSEcCtD
Dipyridamole—Haemoglobin—Capecitabine—colon cancer	0.000265	0.00275	CcSEcCtD
Dipyridamole—Rhinitis—Capecitabine—colon cancer	0.000264	0.00275	CcSEcCtD
Dipyridamole—Haemorrhage—Capecitabine—colon cancer	0.000264	0.00274	CcSEcCtD
Dipyridamole—Hepatitis—Capecitabine—colon cancer	0.000264	0.00274	CcSEcCtD
Dipyridamole—Nervous system disorder—Fluorouracil—colon cancer	0.000263	0.00273	CcSEcCtD
Dipyridamole—Thrombocytopenia—Fluorouracil—colon cancer	0.000263	0.00273	CcSEcCtD
Dipyridamole—Hypoaesthesia—Capecitabine—colon cancer	0.000262	0.00272	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Vincristine—colon cancer	0.000262	0.00272	CcSEcCtD
Dipyridamole—Pharyngitis—Capecitabine—colon cancer	0.000262	0.00272	CcSEcCtD
Dipyridamole—Tachycardia—Fluorouracil—colon cancer	0.000262	0.00272	CcSEcCtD
Dipyridamole—Hypotension—Irinotecan—colon cancer	0.000262	0.00272	CcSEcCtD
Dipyridamole—Paraesthesia—Vincristine—colon cancer	0.000258	0.00268	CcSEcCtD
Dipyridamole—ABCB1—epithelium—colon cancer	0.000252	0.00298	CbGeAlD
Dipyridamole—Paraesthesia—Irinotecan—colon cancer	0.000251	0.00261	CcSEcCtD
Dipyridamole—Hypotension—Fluorouracil—colon cancer	0.000251	0.0026	CcSEcCtD
Dipyridamole—Dyspnoea—Irinotecan—colon cancer	0.00025	0.00259	CcSEcCtD
Dipyridamole—Somnolence—Irinotecan—colon cancer	0.000249	0.00258	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Vincristine—colon cancer	0.000248	0.00258	CcSEcCtD
Dipyridamole—Fatigue—Vincristine—colon cancer	0.000248	0.00257	CcSEcCtD
Dipyridamole—Dyspepsia—Irinotecan—colon cancer	0.000247	0.00256	CcSEcCtD
Dipyridamole—Tinnitus—Capecitabine—colon cancer	0.000246	0.00255	CcSEcCtD
Dipyridamole—Pain—Vincristine—colon cancer	0.000246	0.00255	CcSEcCtD
Dipyridamole—Cardiac disorder—Capecitabine—colon cancer	0.000245	0.00254	CcSEcCtD
Dipyridamole—Flushing—Capecitabine—colon cancer	0.000245	0.00254	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000244	0.00254	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Irinotecan—colon cancer	0.000242	0.00251	CcSEcCtD
Dipyridamole—Fatigue—Irinotecan—colon cancer	0.000241	0.00251	CcSEcCtD
Dipyridamole—Paraesthesia—Fluorouracil—colon cancer	0.000241	0.0025	CcSEcCtD
Dipyridamole—Pain—Irinotecan—colon cancer	0.000239	0.00249	CcSEcCtD
Dipyridamole—Angiopathy—Capecitabine—colon cancer	0.000239	0.00248	CcSEcCtD
Dipyridamole—Dyspnoea—Fluorouracil—colon cancer	0.000239	0.00248	CcSEcCtD
Dipyridamole—Somnolence—Fluorouracil—colon cancer	0.000238	0.00248	CcSEcCtD
Dipyridamole—Immune system disorder—Capecitabine—colon cancer	0.000238	0.00247	CcSEcCtD
Dipyridamole—Mediastinal disorder—Capecitabine—colon cancer	0.000238	0.00247	CcSEcCtD
Dipyridamole—Chills—Capecitabine—colon cancer	0.000237	0.00246	CcSEcCtD
Dipyridamole—Dyspepsia—Fluorouracil—colon cancer	0.000236	0.00245	CcSEcCtD
Dipyridamole—Arrhythmia—Capecitabine—colon cancer	0.000236	0.00245	CcSEcCtD
Dipyridamole—Abdominal discomfort—Methotrexate—colon cancer	0.000235	0.00244	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Vincristine—colon cancer	0.000235	0.00244	CcSEcCtD
Dipyridamole—ABCB1—renal system—colon cancer	0.000234	0.00276	CbGeAlD
Dipyridamole—Alopecia—Capecitabine—colon cancer	0.000233	0.00242	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000232	0.0024	CcSEcCtD
Dipyridamole—Feeling abnormal—Irinotecan—colon cancer	0.000231	0.0024	CcSEcCtD
Dipyridamole—Pain—Fluorouracil—colon cancer	0.000229	0.00238	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Irinotecan—colon cancer	0.000229	0.00238	CcSEcCtD
Dipyridamole—Abdominal pain—Vincristine—colon cancer	0.000227	0.00236	CcSEcCtD
Dipyridamole—Flatulence—Capecitabine—colon cancer	0.000226	0.00235	CcSEcCtD
Dipyridamole—Dysgeusia—Capecitabine—colon cancer	0.000225	0.00233	CcSEcCtD
Dipyridamole—Back pain—Capecitabine—colon cancer	0.000222	0.00231	CcSEcCtD
Dipyridamole—Abdominal pain—Irinotecan—colon cancer	0.000221	0.0023	CcSEcCtD
Dipyridamole—Feeling abnormal—Fluorouracil—colon cancer	0.000221	0.00229	CcSEcCtD
Dipyridamole—Muscle spasms—Capecitabine—colon cancer	0.000221	0.00229	CcSEcCtD
Dipyridamole—Tremor—Capecitabine—colon cancer	0.000215	0.00223	CcSEcCtD
Dipyridamole—Ill-defined disorder—Capecitabine—colon cancer	0.000213	0.00221	CcSEcCtD
Dipyridamole—Urticaria—Fluorouracil—colon cancer	0.000213	0.00221	CcSEcCtD
Dipyridamole—Anaemia—Capecitabine—colon cancer	0.000212	0.0022	CcSEcCtD
Dipyridamole—Hypersensitivity—Vincristine—colon cancer	0.000212	0.0022	CcSEcCtD
Dipyridamole—Malaise—Capecitabine—colon cancer	0.000207	0.00215	CcSEcCtD
Dipyridamole—Vertigo—Capecitabine—colon cancer	0.000206	0.00214	CcSEcCtD
Dipyridamole—Hypersensitivity—Irinotecan—colon cancer	0.000206	0.00214	CcSEcCtD
Dipyridamole—Asthenia—Vincristine—colon cancer	0.000206	0.00214	CcSEcCtD
Dipyridamole—Syncope—Capecitabine—colon cancer	0.000206	0.00214	CcSEcCtD
Dipyridamole—Palpitations—Capecitabine—colon cancer	0.000203	0.00211	CcSEcCtD
Dipyridamole—Loss of consciousness—Capecitabine—colon cancer	0.000202	0.0021	CcSEcCtD
Dipyridamole—Asthenia—Irinotecan—colon cancer	0.000201	0.00209	CcSEcCtD
Dipyridamole—Cough—Capecitabine—colon cancer	0.0002	0.00208	CcSEcCtD
Dipyridamole—Hypertension—Capecitabine—colon cancer	0.000198	0.00206	CcSEcCtD
Dipyridamole—Hypersensitivity—Fluorouracil—colon cancer	0.000198	0.00205	CcSEcCtD
Dipyridamole—Haemoglobin—Methotrexate—colon cancer	0.000197	0.00205	CcSEcCtD
Dipyridamole—Diarrhoea—Vincristine—colon cancer	0.000197	0.00204	CcSEcCtD
Dipyridamole—Hepatitis—Methotrexate—colon cancer	0.000196	0.00204	CcSEcCtD
Dipyridamole—Haemorrhage—Methotrexate—colon cancer	0.000196	0.00204	CcSEcCtD
Dipyridamole—Arthralgia—Capecitabine—colon cancer	0.000196	0.00203	CcSEcCtD
Dipyridamole—Myalgia—Capecitabine—colon cancer	0.000196	0.00203	CcSEcCtD
Dipyridamole—Chest pain—Capecitabine—colon cancer	0.000196	0.00203	CcSEcCtD
Dipyridamole—Pharyngitis—Methotrexate—colon cancer	0.000195	0.00202	CcSEcCtD
Dipyridamole—Anxiety—Capecitabine—colon cancer	0.000195	0.00202	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000194	0.00202	CcSEcCtD
Dipyridamole—ABCB1—lymphoid tissue—colon cancer	0.000194	0.0023	CbGeAlD
Dipyridamole—Discomfort—Capecitabine—colon cancer	0.000193	0.00201	CcSEcCtD
Dipyridamole—ABCB1—digestive system—colon cancer	0.000192	0.00227	CbGeAlD
Dipyridamole—Diarrhoea—Irinotecan—colon cancer	0.000192	0.00199	CcSEcCtD
Dipyridamole—Dry mouth—Capecitabine—colon cancer	0.000191	0.00198	CcSEcCtD
Dipyridamole—Dizziness—Vincristine—colon cancer	0.00019	0.00197	CcSEcCtD
Dipyridamole—Pruritus—Fluorouracil—colon cancer	0.00019	0.00197	CcSEcCtD
Dipyridamole—Oedema—Capecitabine—colon cancer	0.000187	0.00195	CcSEcCtD
Dipyridamole—Dizziness—Irinotecan—colon cancer	0.000185	0.00192	CcSEcCtD
Dipyridamole—Shock—Capecitabine—colon cancer	0.000184	0.00191	CcSEcCtD
Dipyridamole—Nervous system disorder—Capecitabine—colon cancer	0.000184	0.00191	CcSEcCtD
Dipyridamole—Diarrhoea—Fluorouracil—colon cancer	0.000184	0.00191	CcSEcCtD
Dipyridamole—Thrombocytopenia—Capecitabine—colon cancer	0.000184	0.00191	CcSEcCtD
Dipyridamole—Tinnitus—Methotrexate—colon cancer	0.000183	0.0019	CcSEcCtD
Dipyridamole—Tachycardia—Capecitabine—colon cancer	0.000183	0.0019	CcSEcCtD
Dipyridamole—Vomiting—Vincristine—colon cancer	0.000183	0.0019	CcSEcCtD
Dipyridamole—Cardiac disorder—Methotrexate—colon cancer	0.000182	0.00189	CcSEcCtD
Dipyridamole—Skin disorder—Capecitabine—colon cancer	0.000182	0.00189	CcSEcCtD
Dipyridamole—Rash—Vincristine—colon cancer	0.000181	0.00188	CcSEcCtD
Dipyridamole—Hyperhidrosis—Capecitabine—colon cancer	0.000181	0.00188	CcSEcCtD
Dipyridamole—Dermatitis—Vincristine—colon cancer	0.000181	0.00188	CcSEcCtD
Dipyridamole—Headache—Vincristine—colon cancer	0.00018	0.00187	CcSEcCtD
Dipyridamole—Angiopathy—Methotrexate—colon cancer	0.000178	0.00185	CcSEcCtD
Dipyridamole—Vomiting—Irinotecan—colon cancer	0.000178	0.00185	CcSEcCtD
Dipyridamole—Immune system disorder—Methotrexate—colon cancer	0.000177	0.00184	CcSEcCtD
Dipyridamole—Dizziness—Fluorouracil—colon cancer	0.000177	0.00184	CcSEcCtD
Dipyridamole—Mediastinal disorder—Methotrexate—colon cancer	0.000177	0.00184	CcSEcCtD
Dipyridamole—ABCB1—bone marrow—colon cancer	0.000177	0.00209	CbGeAlD
Dipyridamole—Rash—Irinotecan—colon cancer	0.000177	0.00183	CcSEcCtD
Dipyridamole—Dermatitis—Irinotecan—colon cancer	0.000176	0.00183	CcSEcCtD
Dipyridamole—Chills—Methotrexate—colon cancer	0.000176	0.00183	CcSEcCtD
Dipyridamole—Headache—Irinotecan—colon cancer	0.000175	0.00182	CcSEcCtD
Dipyridamole—Hypotension—Capecitabine—colon cancer	0.000175	0.00182	CcSEcCtD
Dipyridamole—Alopecia—Methotrexate—colon cancer	0.000174	0.0018	CcSEcCtD
Dipyridamole—Nausea—Vincristine—colon cancer	0.000171	0.00177	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000171	0.00177	CcSEcCtD
Dipyridamole—Vomiting—Fluorouracil—colon cancer	0.000171	0.00177	CcSEcCtD
Dipyridamole—ABCB1—vagina—colon cancer	0.000169	0.002	CbGeAlD
Dipyridamole—Rash—Fluorouracil—colon cancer	0.000169	0.00176	CcSEcCtD
Dipyridamole—Dermatitis—Fluorouracil—colon cancer	0.000169	0.00175	CcSEcCtD
Dipyridamole—Paraesthesia—Capecitabine—colon cancer	0.000168	0.00175	CcSEcCtD
Dipyridamole—Headache—Fluorouracil—colon cancer	0.000168	0.00174	CcSEcCtD
Dipyridamole—Dysgeusia—Methotrexate—colon cancer	0.000167	0.00174	CcSEcCtD
Dipyridamole—Dyspnoea—Capecitabine—colon cancer	0.000167	0.00173	CcSEcCtD
Dipyridamole—Nausea—Irinotecan—colon cancer	0.000166	0.00173	CcSEcCtD
Dipyridamole—Back pain—Methotrexate—colon cancer	0.000165	0.00172	CcSEcCtD
Dipyridamole—Dyspepsia—Capecitabine—colon cancer	0.000165	0.00171	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Capecitabine—colon cancer	0.000162	0.00168	CcSEcCtD
Dipyridamole—Fatigue—Capecitabine—colon cancer	0.000162	0.00168	CcSEcCtD
Dipyridamole—Pain—Capecitabine—colon cancer	0.00016	0.00166	CcSEcCtD
Dipyridamole—Nausea—Fluorouracil—colon cancer	0.000159	0.00165	CcSEcCtD
Dipyridamole—Ill-defined disorder—Methotrexate—colon cancer	0.000159	0.00165	CcSEcCtD
Dipyridamole—Anaemia—Methotrexate—colon cancer	0.000158	0.00164	CcSEcCtD
Dipyridamole—Feeling abnormal—Capecitabine—colon cancer	0.000154	0.0016	CcSEcCtD
Dipyridamole—Malaise—Methotrexate—colon cancer	0.000154	0.0016	CcSEcCtD
Dipyridamole—Vertigo—Methotrexate—colon cancer	0.000154	0.00159	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Capecitabine—colon cancer	0.000153	0.00159	CcSEcCtD
Dipyridamole—Cough—Methotrexate—colon cancer	0.000149	0.00155	CcSEcCtD
Dipyridamole—Urticaria—Capecitabine—colon cancer	0.000149	0.00155	CcSEcCtD
Dipyridamole—Abdominal pain—Capecitabine—colon cancer	0.000148	0.00154	CcSEcCtD
Dipyridamole—Convulsion—Methotrexate—colon cancer	0.000148	0.00154	CcSEcCtD
Dipyridamole—Arthralgia—Methotrexate—colon cancer	0.000146	0.00151	CcSEcCtD
Dipyridamole—Chest pain—Methotrexate—colon cancer	0.000146	0.00151	CcSEcCtD
Dipyridamole—Myalgia—Methotrexate—colon cancer	0.000146	0.00151	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000145	0.0015	CcSEcCtD
Dipyridamole—Discomfort—Methotrexate—colon cancer	0.000144	0.00149	CcSEcCtD
Dipyridamole—ABCB1—liver—colon cancer	0.000143	0.00169	CbGeAlD
Dipyridamole—Anaphylactic shock—Methotrexate—colon cancer	0.00014	0.00145	CcSEcCtD
Dipyridamole—Hypersensitivity—Capecitabine—colon cancer	0.000138	0.00143	CcSEcCtD
Dipyridamole—Nervous system disorder—Methotrexate—colon cancer	0.000137	0.00142	CcSEcCtD
Dipyridamole—Thrombocytopenia—Methotrexate—colon cancer	0.000137	0.00142	CcSEcCtD
Dipyridamole—Skin disorder—Methotrexate—colon cancer	0.000136	0.00141	CcSEcCtD
Dipyridamole—Hyperhidrosis—Methotrexate—colon cancer	0.000135	0.0014	CcSEcCtD
Dipyridamole—Asthenia—Capecitabine—colon cancer	0.000134	0.0014	CcSEcCtD
Dipyridamole—Pruritus—Capecitabine—colon cancer	0.000133	0.00138	CcSEcCtD
Dipyridamole—Hypotension—Methotrexate—colon cancer	0.00013	0.00135	CcSEcCtD
Dipyridamole—Diarrhoea—Capecitabine—colon cancer	0.000128	0.00133	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000127	0.00132	CcSEcCtD
Dipyridamole—Paraesthesia—Methotrexate—colon cancer	0.000125	0.0013	CcSEcCtD
Dipyridamole—Dyspnoea—Methotrexate—colon cancer	0.000124	0.00129	CcSEcCtD
Dipyridamole—Somnolence—Methotrexate—colon cancer	0.000124	0.00129	CcSEcCtD
Dipyridamole—Dizziness—Capecitabine—colon cancer	0.000124	0.00129	CcSEcCtD
Dipyridamole—Dyspepsia—Methotrexate—colon cancer	0.000123	0.00127	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Methotrexate—colon cancer	0.00012	0.00125	CcSEcCtD
Dipyridamole—Fatigue—Methotrexate—colon cancer	0.00012	0.00125	CcSEcCtD
Dipyridamole—Pain—Methotrexate—colon cancer	0.000119	0.00124	CcSEcCtD
Dipyridamole—Vomiting—Capecitabine—colon cancer	0.000119	0.00124	CcSEcCtD
Dipyridamole—Rash—Capecitabine—colon cancer	0.000118	0.00123	CcSEcCtD
Dipyridamole—Dermatitis—Capecitabine—colon cancer	0.000118	0.00123	CcSEcCtD
Dipyridamole—Headache—Capecitabine—colon cancer	0.000117	0.00122	CcSEcCtD
Dipyridamole—Feeling abnormal—Methotrexate—colon cancer	0.000115	0.00119	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Methotrexate—colon cancer	0.000114	0.00118	CcSEcCtD
Dipyridamole—Nausea—Capecitabine—colon cancer	0.000111	0.00116	CcSEcCtD
Dipyridamole—Urticaria—Methotrexate—colon cancer	0.000111	0.00115	CcSEcCtD
Dipyridamole—Abdominal pain—Methotrexate—colon cancer	0.00011	0.00114	CcSEcCtD
Dipyridamole—ABCB1—lymph node—colon cancer	0.000109	0.0013	CbGeAlD
Dipyridamole—Hypersensitivity—Methotrexate—colon cancer	0.000103	0.00107	CcSEcCtD
Dipyridamole—Asthenia—Methotrexate—colon cancer	0.0001	0.00104	CcSEcCtD
Dipyridamole—Pruritus—Methotrexate—colon cancer	9.87e-05	0.00102	CcSEcCtD
Dipyridamole—Diarrhoea—Methotrexate—colon cancer	9.55e-05	0.000991	CcSEcCtD
Dipyridamole—Dizziness—Methotrexate—colon cancer	9.23e-05	0.000958	CcSEcCtD
Dipyridamole—Vomiting—Methotrexate—colon cancer	8.87e-05	0.000921	CcSEcCtD
Dipyridamole—Rash—Methotrexate—colon cancer	8.8e-05	0.000913	CcSEcCtD
Dipyridamole—Dermatitis—Methotrexate—colon cancer	8.79e-05	0.000912	CcSEcCtD
Dipyridamole—Headache—Methotrexate—colon cancer	8.74e-05	0.000907	CcSEcCtD
Dipyridamole—Nausea—Methotrexate—colon cancer	8.29e-05	0.00086	CcSEcCtD
Dipyridamole—ADA—Metabolism—EP300—colon cancer	1.77e-05	0.000186	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—MYC—colon cancer	1.76e-05	0.000185	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TGFB1—colon cancer	1.75e-05	0.000185	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—AKT1—colon cancer	1.75e-05	0.000185	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—KRAS—colon cancer	1.75e-05	0.000185	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—KRAS—colon cancer	1.75e-05	0.000185	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—HRAS—colon cancer	1.75e-05	0.000185	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—BRAF—colon cancer	1.75e-05	0.000184	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CDKN1A—colon cancer	1.74e-05	0.000184	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—AKT1—colon cancer	1.74e-05	0.000184	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—MYC—colon cancer	1.73e-05	0.000183	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—PIK3CA—colon cancer	1.73e-05	0.000183	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—PIK3CA—colon cancer	1.73e-05	0.000182	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TGFB1—colon cancer	1.73e-05	0.000182	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—AKT1—colon cancer	1.72e-05	0.000182	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—EGFR—colon cancer	1.72e-05	0.000181	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—AKT1—colon cancer	1.71e-05	0.000181	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—KRAS—colon cancer	1.71e-05	0.00018	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—APC—colon cancer	1.7e-05	0.000179	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—NRAS—colon cancer	1.7e-05	0.000179	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—BRAF—colon cancer	1.7e-05	0.000179	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—EGFR—colon cancer	1.69e-05	0.000179	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—FGFR3—colon cancer	1.69e-05	0.000179	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—EGFR—colon cancer	1.69e-05	0.000179	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—MYC—colon cancer	1.69e-05	0.000178	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PTGS2—colon cancer	1.68e-05	0.000178	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TGFB1—colon cancer	1.68e-05	0.000178	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TP53—colon cancer	1.67e-05	0.000177	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—EP300—colon cancer	1.66e-05	0.000175	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.65e-05	0.000174	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—EGFR—colon cancer	1.65e-05	0.000174	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CTNNB1—colon cancer	1.65e-05	0.000174	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CTNNB1—colon cancer	1.65e-05	0.000174	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.65e-05	0.000174	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—EGFR—colon cancer	1.65e-05	0.000174	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CTNNB1—colon cancer	1.63e-05	0.000172	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—PIK3CA—colon cancer	1.62e-05	0.000171	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—KRAS—colon cancer	1.62e-05	0.000171	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—PIK3CA—colon cancer	1.62e-05	0.000171	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.62e-05	0.000171	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—SRC—colon cancer	1.61e-05	0.00017	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CDKN1A—colon cancer	1.61e-05	0.00017	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CDKN1A—colon cancer	1.61e-05	0.00017	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—PIK3CA—colon cancer	1.61e-05	0.00017	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—PIK3CA—colon cancer	1.61e-05	0.00017	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—KRAS—colon cancer	1.6e-05	0.000169	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—HRAS—colon cancer	1.6e-05	0.000169	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—KRAS—colon cancer	1.6e-05	0.000169	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—BRAF—colon cancer	1.6e-05	0.000169	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CDKN1A—colon cancer	1.6e-05	0.000168	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—AKT1—colon cancer	1.58e-05	0.000167	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—AKT1—colon cancer	1.58e-05	0.000167	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—AKT1—colon cancer	1.57e-05	0.000166	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—PIK3CA—colon cancer	1.57e-05	0.000166	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TP53—colon cancer	1.57e-05	0.000166	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—PIK3CA—colon cancer	1.57e-05	0.000166	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—KRAS—colon cancer	1.56e-05	0.000165	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—KRAS—colon cancer	1.56e-05	0.000164	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TP53—colon cancer	1.55e-05	0.000164	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TP53—colon cancer	1.55e-05	0.000164	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—APC—colon cancer	1.55e-05	0.000164	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—NRAS—colon cancer	1.55e-05	0.000164	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—NRAS—colon cancer	1.55e-05	0.000164	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—EGFR—colon cancer	1.55e-05	0.000163	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—AKT1—colon cancer	1.54e-05	0.000163	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PTGS2—colon cancer	1.54e-05	0.000163	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—EP300—colon cancer	1.53e-05	0.000162	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—EP300—colon cancer	1.53e-05	0.000162	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.53e-05	0.000161	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—EP300—colon cancer	1.52e-05	0.00016	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CTNNB1—colon cancer	1.51e-05	0.000159	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—HRAS—colon cancer	1.5e-05	0.000159	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—SRC—colon cancer	1.49e-05	0.000157	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—SRC—colon cancer	1.49e-05	0.000157	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—PIK3CA—colon cancer	1.49e-05	0.000157	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—HRAS—colon cancer	1.49e-05	0.000157	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—HRAS—colon cancer	1.49e-05	0.000157	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—PIK3CA—colon cancer	1.48e-05	0.000156	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—SRC—colon cancer	1.48e-05	0.000156	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CDKN1A—colon cancer	1.47e-05	0.000155	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—PIK3CA—colon cancer	1.47e-05	0.000155	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—PIK3CA—colon cancer	1.47e-05	0.000155	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—KRAS—colon cancer	1.46e-05	0.000154	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—BRAF—colon cancer	1.46e-05	0.000154	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—HRAS—colon cancer	1.45e-05	0.000153	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TP53—colon cancer	1.44e-05	0.000152	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—NRAS—colon cancer	1.43e-05	0.000151	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—NRAS—colon cancer	1.43e-05	0.000151	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—PIK3CA—colon cancer	1.43e-05	0.000151	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—PIK3CA—colon cancer	1.43e-05	0.000151	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TP53—colon cancer	1.42e-05	0.00015	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—NRAS—colon cancer	1.42e-05	0.00015	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—EGFR—colon cancer	1.42e-05	0.000149	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—EGFR—colon cancer	1.41e-05	0.000149	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—AKT1—colon cancer	1.41e-05	0.000149	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—AKT1—colon cancer	1.41e-05	0.000149	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.4e-05	0.000148	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—EP300—colon cancer	1.4e-05	0.000148	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CASP3—colon cancer	1.4e-05	0.000148	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TP53—colon cancer	1.39e-05	0.000146	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—HRAS—colon cancer	1.38e-05	0.000146	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—SRC—colon cancer	1.36e-05	0.000144	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CCND1—colon cancer	1.36e-05	0.000144	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—HRAS—colon cancer	1.36e-05	0.000144	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—HRAS—colon cancer	1.36e-05	0.000143	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.36e-05	0.000143	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—PIK3CA—colon cancer	1.35e-05	0.000143	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CTNNB1—colon cancer	1.35e-05	0.000142	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—PIK3CA—colon cancer	1.34e-05	0.000142	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—KRAS—colon cancer	1.34e-05	0.000141	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—KRAS—colon cancer	1.34e-05	0.000141	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—MYC—colon cancer	1.34e-05	0.000141	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—MYC—colon cancer	1.34e-05	0.000141	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—TGFB1—colon cancer	1.33e-05	0.000141	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—TGFB1—colon cancer	1.33e-05	0.000141	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—AKT1—colon cancer	1.33e-05	0.00014	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—HRAS—colon cancer	1.33e-05	0.00014	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—HRAS—colon cancer	1.32e-05	0.00014	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—AKT1—colon cancer	1.32e-05	0.00014	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CDKN1A—colon cancer	1.32e-05	0.000139	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—AKT1—colon cancer	1.31e-05	0.000139	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—AKT1—colon cancer	1.31e-05	0.000139	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—NRAS—colon cancer	1.31e-05	0.000138	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CASP3—colon cancer	1.31e-05	0.000138	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—PIK3CA—colon cancer	1.31e-05	0.000138	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—EGFR—colon cancer	1.31e-05	0.000138	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—EGFR—colon cancer	1.31e-05	0.000138	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—EGFR—colon cancer	1.29e-05	0.000137	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—AKT1—colon cancer	1.29e-05	0.000136	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—EP300—colon cancer	1.28e-05	0.000135	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—AKT1—colon cancer	1.28e-05	0.000135	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CCND1—colon cancer	1.27e-05	0.000135	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CASP3—colon cancer	1.27e-05	0.000134	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CTNNB1—colon cancer	1.26e-05	0.000133	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—EP300—colon cancer	1.25e-05	0.000132	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—HRAS—colon cancer	1.24e-05	0.000131	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CCND1—colon cancer	1.24e-05	0.000131	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—KRAS—colon cancer	1.23e-05	0.00013	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—KRAS—colon cancer	1.23e-05	0.00013	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CDKN1A—colon cancer	1.23e-05	0.00013	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—PIK3CA—colon cancer	1.23e-05	0.00013	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CTNNB1—colon cancer	1.23e-05	0.00013	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—PIK3CA—colon cancer	1.23e-05	0.00013	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—KRAS—colon cancer	1.22e-05	0.000129	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MYC—colon cancer	1.22e-05	0.000129	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—SRC—colon cancer	1.22e-05	0.000129	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—TGFB1—colon cancer	1.22e-05	0.000129	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—AKT1—colon cancer	1.22e-05	0.000129	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—AKT1—colon cancer	1.21e-05	0.000128	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—AKT1—colon cancer	1.2e-05	0.000127	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—AKT1—colon cancer	1.2e-05	0.000127	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CDKN1A—colon cancer	1.2e-05	0.000127	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CASP3—colon cancer	1.2e-05	0.000126	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—EGFR—colon cancer	1.19e-05	0.000126	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—VEGFA—colon cancer	1.19e-05	0.000125	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—EP300—colon cancer	1.17e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—NRAS—colon cancer	1.17e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—AKT1—colon cancer	1.17e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—AKT1—colon cancer	1.17e-05	0.000123	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CCND1—colon cancer	1.17e-05	0.000123	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CTNNB1—colon cancer	1.15e-05	0.000122	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.15e-05	0.000121	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—EP300—colon cancer	1.14e-05	0.00012	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—SRC—colon cancer	1.14e-05	0.00012	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—HRAS—colon cancer	1.14e-05	0.00012	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—HRAS—colon cancer	1.14e-05	0.00012	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—PIK3CA—colon cancer	1.13e-05	0.00012	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—PIK3CA—colon cancer	1.13e-05	0.00012	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—KRAS—colon cancer	1.13e-05	0.000119	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CDKN1A—colon cancer	1.13e-05	0.000119	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—PIK3CA—colon cancer	1.12e-05	0.000119	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—VEGFA—colon cancer	1.11e-05	0.000117	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—SRC—colon cancer	1.11e-05	0.000117	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—AKT1—colon cancer	1.11e-05	0.000117	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—AKT1—colon cancer	1.1e-05	0.000116	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—NRAS—colon cancer	1.1e-05	0.000116	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CASP3—colon cancer	1.1e-05	0.000116	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MYC—colon cancer	1.09e-05	0.000115	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TGFB1—colon cancer	1.09e-05	0.000115	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—VEGFA—colon cancer	1.08e-05	0.000114	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—EP300—colon cancer	1.07e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—EGFR—colon cancer	1.07e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—NRAS—colon cancer	1.07e-05	0.000113	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—AKT1—colon cancer	1.07e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCND1—colon cancer	1.07e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CTNNB1—colon cancer	1.06e-05	0.000111	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—HRAS—colon cancer	1.05e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—HRAS—colon cancer	1.05e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—SRC—colon cancer	1.04e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HRAS—colon cancer	1.04e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PIK3CA—colon cancer	1.04e-05	0.000109	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CDKN1A—colon cancer	1.03e-05	0.000109	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MYC—colon cancer	1.02e-05	0.000108	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TGFB1—colon cancer	1.02e-05	0.000108	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—VEGFA—colon cancer	1.02e-05	0.000107	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—KRAS—colon cancer	1.01e-05	0.000107	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—AKT1—colon cancer	1e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—NRAS—colon cancer	1e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—AKT1—colon cancer	1e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—EGFR—colon cancer	1e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MYC—colon cancer	9.94e-06	0.000105	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TGFB1—colon cancer	9.92e-06	0.000105	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—EP300—colon cancer	9.81e-06	0.000104	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—EGFR—colon cancer	9.73e-06	0.000103	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—HRAS—colon cancer	9.59e-06	0.000101	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—SRC—colon cancer	9.54e-06	0.000101	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PIK3CA—colon cancer	9.49e-06	0.0001	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—KRAS—colon cancer	9.45e-06	9.97e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MYC—colon cancer	9.35e-06	9.87e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TGFB1—colon cancer	9.33e-06	9.85e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—VEGFA—colon cancer	9.29e-06	9.81e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PIK3CA—colon cancer	9.27e-06	9.79e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—AKT1—colon cancer	9.26e-06	9.78e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—AKT1—colon cancer	9.26e-06	9.78e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—KRAS—colon cancer	9.19e-06	9.7e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NRAS—colon cancer	9.18e-06	9.69e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—AKT1—colon cancer	9.17e-06	9.68e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—EGFR—colon cancer	9.15e-06	9.66e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TP53—colon cancer	8.97e-06	9.47e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PIK3CA—colon cancer	8.68e-06	9.16e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—KRAS—colon cancer	8.64e-06	9.12e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—HRAS—colon cancer	8.58e-06	9.05e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MYC—colon cancer	8.55e-06	9.03e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TGFB1—colon cancer	8.53e-06	9.01e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—AKT1—colon cancer	8.47e-06	8.94e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PIK3CA—colon cancer	8.44e-06	8.91e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TP53—colon cancer	8.4e-06	8.86e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—EGFR—colon cancer	8.36e-06	8.83e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TP53—colon cancer	8.17e-06	8.62e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—HRAS—colon cancer	8.03e-06	8.48e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PIK3CA—colon cancer	7.94e-06	8.38e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—KRAS—colon cancer	7.9e-06	8.34e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—HRAS—colon cancer	7.81e-06	8.25e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—AKT1—colon cancer	7.75e-06	8.19e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TP53—colon cancer	7.68e-06	8.11e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—TYMS—colon cancer	7.61e-06	8.03e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—AKT1—colon cancer	7.57e-06	7.99e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—HRAS—colon cancer	7.34e-06	7.75e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PIK3CA—colon cancer	7.26e-06	7.66e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—AKT1—colon cancer	7.09e-06	7.48e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TP53—colon cancer	7.02e-06	7.41e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—AKT1—colon cancer	6.9e-06	7.28e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—HRAS—colon cancer	6.72e-06	7.09e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—AKT1—colon cancer	6.48e-06	6.85e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—AKT1—colon cancer	5.93e-06	6.26e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PPARG—colon cancer	5.39e-06	5.69e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTGS2—colon cancer	4.24e-06	4.48e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—EP300—colon cancer	3.53e-06	3.72e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PIK3CA—colon cancer	2.61e-06	2.75e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—AKT1—colon cancer	2.13e-06	2.25e-05	CbGpPWpGaD
